<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">

<channel>

<title>DailyUpdates from LeadDiscovery: Breaking Research, Development News and Pharmareports for Drug Discovery</title>

<link>http://www.leaddiscovery.co.uk</link>

<description>Dedicated to drug discovery, LeadDiscovery was founded in 1998 by life scientists for life scientists.</description>

<lastBuildDate>Thu, 09 Feb 2012 21:56:55 GMT</lastBuildDate>

<image>

<title>DailyUpdates</title>

<link>http://www.leaddiscovery.co.uk</link>

<description>Breaking Research, Development News and Pharmareports for Drug Discovery</description>

<url>http://www.leaddiscovery.co.uk/dailyupdates_RSS_Icon.gif</url>

<width>144</width>

<height>59</height>

</image>


<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/dailyupdates" /><feedburner:info uri="dailyupdates" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/22137068/dailyupdate?1</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/vT8j-T_T2lI/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.</title>

<description>Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction....&lt;a href="http://www.leaddiscovery.co.uk/articles/22137068/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/22137068/dailyupdate?1</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/21956443/dailyupdate?2</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/l6YLzHEw1n8/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.</title>

<description>Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia....&lt;a href="http://www.leaddiscovery.co.uk/articles/21956443/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/21956443/dailyupdate?2</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/22030716/dailyupdate?3</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/H7-_KBmijFc/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats.</title>

<description>Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats....&lt;a href="http://www.leaddiscovery.co.uk/articles/22030716/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/22030716/dailyupdate?3</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/22236931/dailyupdate?4</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/xBG3DMGUSn8/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>Quitting smoking with varenicline: parallel randomised efficacy trial in Iran.</title>

<description>Quitting smoking with varenicline: parallel randomised efficacy trial in Iran....&lt;a href="http://www.leaddiscovery.co.uk/articles/22236931/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/22236931/dailyupdate?4</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/22119468/dailyupdate?5</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/z7hytbA10sM/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>() - 2 - (N - tert - Butylamino) - 3 - (125)I - iodo - 4 - azidopropiophenone: A dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin Zyban).</title>

<description>() - 2 - (N - tert - Butylamino) - 3 - (125)I - iodo - 4 - azidopropiophenone: A dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin Zyban)....&lt;a href="http://www.leaddiscovery.co.uk/articles/22119468/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/22119468/dailyupdate?5</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/22123706/dailyupdate?6</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/5DP7kJK1HRI/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>Symptomatic Hyperbilirubinemia Secondary to Dapsone Induced Hemolysis and Atazanavir Therapy.</title>

<description>Symptomatic Hyperbilirubinemia Secondary to Dapsone Induced Hemolysis and Atazanavir Therapy....&lt;a href="http://www.leaddiscovery.co.uk/articles/22123706/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/22123706/dailyupdate?6</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/22137787/dailyupdate?7</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/91HN50NOiqQ/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E(2) synthase - 1 inhibitors.</title>

<description>Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E(2) synthase - 1 inhibitors....&lt;a href="http://www.leaddiscovery.co.uk/articles/22137787/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/22137787/dailyupdate?7</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/22137342/dailyupdate?8</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/9zNtOd2A-Rg/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>Discovery and optimization of thieno23 - dpyrimidines as B - Raf inhibitors.</title>

<description>Discovery and optimization of thieno23 - dpyrimidines as B - Raf inhibitors....&lt;a href="http://www.leaddiscovery.co.uk/articles/22137342/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/22137342/dailyupdate?8</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/22123713/dailyupdate?9</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/re5buVy0YYo/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>Does Severe Anemia Caused by Dose-Dense Paclitaxel-Carboplatin Combination Therapy Have an Effect on the Survival of Patients With Epithelial Ovarian Cancer Retrospective Analysis of the Japanese Gynecologic Oncology Group 3016 Trial.</title>

<description>Does Severe Anemia Caused by Dose-Dense Paclitaxel-Carboplatin Combination Therapy Have an Effect on the Survival of Patients With Epithelial Ovarian Cancer Retrospective Analysis of the Japanese Gynecologic Oncology Group 3016 Trial....&lt;a href="http://www.leaddiscovery.co.uk/articles/22123713/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/22123713/dailyupdate?9</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/22137847/dailyupdate?10</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/Z01o3tnzzGE/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>Design and diversity - oriented synthesis of novel 14 - thiazepan - 3 - ones fused with bioactive heterocyclic skeletons and evaluation of their antioxidant and cytotoxic activities.</title>

<description>Design and diversity - oriented synthesis of novel 14 - thiazepan - 3 - ones fused with bioactive heterocyclic skeletons and evaluation of their antioxidant and cytotoxic activities....&lt;a href="http://www.leaddiscovery.co.uk/articles/22137847/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/22137847/dailyupdate?10</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/articles/22124154/dailyupdate?11</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/P3AEB_1fvIY/dailyupdate</link>

<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>

<title>A Novel Function of p38-RegulatedActivated Kinase (PRAK) In Endothelial Cell Migration and Tumor Angiogenesis.</title>

<description>A Novel Function of p38-RegulatedActivated Kinase (PRAK) In Endothelial Cell Migration and Tumor Angiogenesis....&lt;a href="http://www.leaddiscovery.co.uk/articles/22124154/dailyupdate"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/articles/22124154/dailyupdate?11</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/news/10065?12</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/1Id0VR5CLAc/10065</link>

<pubDate>Thu, 09 Feb 2012 21:56:53 GMT</pubDate>

<title>Amgen to Discuss Application for New Use of XGEVA (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting</title>

<description>Amgen to Discuss Application for New Use of XGEVA (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting...&lt;a href="http://www.leaddiscovery.co.uk/news/10065"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/news/10065?12</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/news/10066?13</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/P8jOmb9J0NY/10066</link>

<pubDate>Thu, 09 Feb 2012 21:56:53 GMT</pubDate>

<title>Forest Laboratories Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder</title>

<description>Forest Laboratories Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder...&lt;a href="http://www.leaddiscovery.co.uk/news/10066"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/news/10066?13</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/news/10064?14</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/6BS4Eb_oBEU/10064</link>

<pubDate>Thu, 09 Feb 2012 21:56:53 GMT</pubDate>

<title>BioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review for Phase III Program</title>

<description>BioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review for Phase III Program...&lt;a href="http://www.leaddiscovery.co.uk/news/10064"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/news/10064?14</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/news/10063?15</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/ucwHqOJ7_U4/10063</link>

<pubDate>Thu, 09 Feb 2012 21:56:53 GMT</pubDate>

<title>FDA Sets Shortcut Path for Biosimilar Drugs</title>

<description>FDA Sets Shortcut Path for Biosimilar Drugs...&lt;a href="http://www.leaddiscovery.co.uk/news/10063"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/news/10063?15</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/news/10067?16</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/epP1U1D_Btg/10067</link>

<pubDate>Thu, 09 Feb 2012 21:56:53 GMT</pubDate>

<title>OptiNose Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology</title>

<description>OptiNose Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology...&lt;a href="http://www.leaddiscovery.co.uk/news/10067"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/news/10067?16</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/trials/11111?17</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/I07iY8DLE4g/11111</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>Nesiritide in Resistant Hypertension</title>

<description>Nesiritide in Resistant Hypertension...&lt;a href="http://www.leaddiscovery.co.uk/trials/11111"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/trials/11111?17</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/trials/11105?18</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/ER2qPuHEYV8/11105</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>A Study to Evaluate the PKPD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment</title>

<description>A Study to Evaluate the PKPD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment...&lt;a href="http://www.leaddiscovery.co.uk/trials/11105"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/trials/11105?18</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/trials/11095?19</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/n0Lpl5-cbk0/11095</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic HCV-1 and HIV-1</title>

<description>An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic HCV-1 and HIV-1...&lt;a href="http://www.leaddiscovery.co.uk/trials/11095"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/trials/11095?19</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/trials/11093?20</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/25--L97c6pM/11093</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis</title>

<description>Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis...&lt;a href="http://www.leaddiscovery.co.uk/trials/11093"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/trials/11093?20</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/trials/11092?21</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/zMZVBddkXuc/11092</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)</title>

<description>A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)...&lt;a href="http://www.leaddiscovery.co.uk/trials/11092"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/trials/11092?21</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/trials/11104?22</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/4sE6lLY1vr4/11104</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>Safety Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis</title>

<description>Safety Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis...&lt;a href="http://www.leaddiscovery.co.uk/trials/11104"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/trials/11104?22</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/trials/11106?23</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/WtUukwQWA4k/11106</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced andor Metastatic Cancer</title>

<description>Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced andor Metastatic Cancer...&lt;a href="http://www.leaddiscovery.co.uk/trials/11106"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/trials/11106?23</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/trials/10179?24</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/BIsG2GMYfUI/10179</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>Safety and PK Study of RRx-001 in Cancer Subjects</title>

<description>Safety and PK Study of RRx-001 in Cancer Subjects...&lt;a href="http://www.leaddiscovery.co.uk/trials/10179"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/trials/10179?24</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/trials/10172?25</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/pwFgJqkYH0E/10172</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder</title>

<description>Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder...&lt;a href="http://www.leaddiscovery.co.uk/trials/10172"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/trials/10172?25</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/trials/10169?26</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/Cd3kSHOKYbU/10169</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors</title>

<description>CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors...&lt;a href="http://www.leaddiscovery.co.uk/trials/10169"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/trials/10169?26</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/reports/2105?27</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/_CC73P5pxqY/2105</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title>

<description>Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018...&lt;a href="http://www.leaddiscovery.co.uk/reports/2105"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/reports/2105?27</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/reports/2106?28</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/jDq9LH4jyoA/2106</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title>

<description>Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018...&lt;a href="http://www.leaddiscovery.co.uk/reports/2106"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/reports/2106?28</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/reports/2108?29</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/ymC8IXFfh8I/2108</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title>

<description>Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018...&lt;a href="http://www.leaddiscovery.co.uk/reports/2108"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/reports/2108?29</feedburner:origLink></item>


<item>

<guid isPermaLink="false">http://www.leaddiscovery.co.uk/reports/2109?30</guid>

<link>http://feedproxy.google.com/~r/dailyupdates/~3/nobThXDDj2Q/2109</link>

<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>

<title>Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title>

<description>Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018...&lt;a href="http://www.leaddiscovery.co.uk/reports/2109"&gt;Read More&lt;/a&gt;</description>

<feedburner:origLink>http://www.leaddiscovery.co.uk/reports/2109?30</feedburner:origLink></item>


</channel>

</rss>

